NovelStem International NSTM
OTC NSTM
$0.01 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

NovelStem International (NSTM) Gains from Equity Investments (2010 - 2013)

Updated

NovelStem International (NSTM) recorded Gains from Equity Investments of $1,063 in Q3 2021.

Analysis

NovelStem International (NSTM) Gains from Equity Investments (2010 - 2013) Analysis & Trends

On a TTM basis, NovelStem International's Gains from Equity Investments came in at $618.00 as of Sep 30, 2013; for FY2012, it came in at -$324,649.

  • Across earlier years, Gains from Equity Investments came in at -$526,179 in FY2011, $724,968 in FY2010 (+645.1%) and $97,297 in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 NovelStem International 493,324.54 346,279.54 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 1,063.00
Jun 30, 2013 -140.00
Mar 31, 2013 -152.00
Dec 31, 2012 -153.00
Sep 30, 2012 -175,970.00
Jun 30, 2012 -150,754.00
Mar 31, 2012 2,228.00
Dec 31, 2011 115,518.00
Sep 30, 2011 -820,104.00
Jun 30, 2011 115,282.00
Mar 31, 2011 63,125.00
Dec 31, 2010 128,176.00
Sep 30, 2010 76,459.00
API Access

NovelStem International Gains from Equity Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=NSTM&period=max&api_key=YOUR_API_KEY